Mycophenolic Acid, LC/MS/MS : 10662

Test Code
MYCOA or 10662


CPT Codes
80180

Includes
Mycophenolic Acid and MPA Glucuronide


Instructions
Optimum time to collect sample: 1/2 hour to 1 hour before next dose (trough) at steady-state (3-5 days after treatment with oral doses)


Transport Container
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
 
Alternative Specimens
Plasma collected in: Sodium heparin (green-top) tube or EDTA (lavender-top) tube
 
Minimum Volume
0.5 mL
 
Collection Instructions
Serum: Collect blood in plain red-top (no gel) tube. Allow blood to clot at 15-28°C for 20-30 minutes. Centrifuge at 20-25°C (2200-2500 rpm, 1000 x g) for 8-10 minutes. Transfer serum to polypropylene or polyethylene transport tube. Ship refrigerated (cold packs). Samples left at room temperature for more than 3 days are not acceptable.

Plasma: Draw blood into EDTA lavender-top tube. Separate cells by centrifugation at 18-25°C (2500-2800 rpm) for 5-10 minutes. Transfer plasma to polypropylene or polyethylene transport tube. Ship refrigerated (cold packs). Samples left at room temperature for more than 3 days are not acceptable.


Transport Temperature
Refrigerated.


Specimen Stability
Room temperature: 72 hours; Refrigerated: 14 days; Frozen: 60 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis. Lipemia. Specimens left at room temperature greater than 72 hours. Gel barrier/Serum Separator Tube (SST)


Methodology
Chromatography/Mass Spectrometry

Setup Schedule
Monday - Saturday


Report Available
3 days  (From receipt at performing laboratory)


Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.


Reference Range
Mycophenolic Acid 1.0-3.5 mcg/mL 
MPA Glucuronide 35.0-100.0 mcg/mL 


Clinical Significance
Mycophenolic acid is an immunosuppressant used in tissue transplants. It prevents graft rejection by the host's immune system. It is very important to monitor its level. Too little of this drug will cause graft rejection, while too much will lead to infection. Monitoring its level is essential to optimize therapeutic effects, avoid toxicity, and assure compliance.


Performing Laboratory
Quest Diagnostics



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.